nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—ADRB2—autistic disorder	0.848	1	CbGaD
Bupranolol—Pirbuterol—ADRB2—autistic disorder	0.00109	0.0993	CrCbGaD
Bupranolol—Levobunolol—ADRB2—autistic disorder	0.000971	0.0885	CrCbGaD
Bupranolol—Timolol—ADRB2—autistic disorder	0.000926	0.0844	CrCbGaD
Bupranolol—Bopindolol—HTR1B—autistic disorder	0.000905	0.0825	CrCbGaD
Bupranolol—Terbutaline—ADRB2—autistic disorder	0.000888	0.0809	CrCbGaD
Bupranolol—Penbutolol—HTR1B—autistic disorder	0.000863	0.0787	CrCbGaD
Bupranolol—Carteolol—ADRB2—autistic disorder	0.000825	0.0752	CrCbGaD
Bupranolol—Nadolol—ADRB2—autistic disorder	0.000736	0.0671	CrCbGaD
Bupranolol—Clenbuterol—ADRB2—autistic disorder	0.00071	0.0647	CrCbGaD
Bupranolol—Bopindolol—ADRB2—autistic disorder	0.000673	0.0613	CrCbGaD
Bupranolol—Salbutamol—ADRB2—autistic disorder	0.00066	0.0602	CrCbGaD
Bupranolol—Penbutolol—ADRB2—autistic disorder	0.000642	0.0585	CrCbGaD
Bupranolol—Pindolol—HTR1B—autistic disorder	0.000622	0.0567	CrCbGaD
Bupranolol—Pindolol—ADRB2—autistic disorder	0.000463	0.0422	CrCbGaD
Bupranolol—ADRB1—Signaling Pathways—NRP2—autistic disorder	9.35e-05	0.000662	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—AVP—autistic disorder	9.31e-05	0.000659	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AVPR1A—autistic disorder	9.21e-05	0.000652	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—ADM—autistic disorder	9.16e-05	0.000648	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—GABBR1—autistic disorder	9.16e-05	0.000648	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NRP2—autistic disorder	9.15e-05	0.000648	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—AVP—autistic disorder	9.1e-05	0.000645	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—VIP—autistic disorder	9.09e-05	0.000644	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—GRM5—autistic disorder	9.09e-05	0.000644	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GRM5—autistic disorder	9.05e-05	0.000641	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—VIP—autistic disorder	9.05e-05	0.000641	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR5A—autistic disorder	8.96e-05	0.000635	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—GABBR1—autistic disorder	8.96e-05	0.000634	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—ADM—autistic disorder	8.96e-05	0.000634	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PDE4B—autistic disorder	8.92e-05	0.000632	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—GRM5—autistic disorder	8.89e-05	0.00063	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—VIP—autistic disorder	8.89e-05	0.00063	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—AVP—autistic disorder	8.86e-05	0.000627	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—OXTR—autistic disorder	8.8e-05	0.000624	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR5A—autistic disorder	8.77e-05	0.000621	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—OXTR—autistic disorder	8.76e-05	0.000621	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PDE4B—autistic disorder	8.73e-05	0.000618	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—SCT—autistic disorder	8.72e-05	0.000617	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SCT—autistic disorder	8.67e-05	0.000614	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—OPRM1—autistic disorder	8.64e-05	0.000612	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—OXTR—autistic disorder	8.61e-05	0.00061	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—ADRB2—autistic disorder	8.56e-05	0.000606	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—SCT—autistic disorder	8.53e-05	0.000604	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—OPRM1—autistic disorder	8.45e-05	0.000599	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—ADM—autistic disorder	8.31e-05	0.000589	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—GABBR1—autistic disorder	8.31e-05	0.000589	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADM—autistic disorder	8.28e-05	0.000586	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GABBR1—autistic disorder	8.28e-05	0.000586	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—GABBR1—autistic disorder	8.13e-05	0.000576	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—ADM—autistic disorder	8.13e-05	0.000576	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EIF4E—autistic disorder	8.13e-05	0.000576	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	8.12e-05	0.000575	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PDE4B—autistic disorder	8.1e-05	0.000574	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PDE4B—autistic disorder	8.06e-05	0.000571	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—AVP—autistic disorder	8.05e-05	0.00057	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	7.94e-05	0.000563	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PDE4B—autistic disorder	7.93e-05	0.000561	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—OPRM1—autistic disorder	7.85e-05	0.000556	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—OPRM1—autistic disorder	7.81e-05	0.000553	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR2A—autistic disorder	7.74e-05	0.000548	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—OPRM1—autistic disorder	7.68e-05	0.000544	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR1B—autistic disorder	7.67e-05	0.000543	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—OXT—autistic disorder	7.67e-05	0.000543	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GABBR2—autistic disorder	7.62e-05	0.00054	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR2A—autistic disorder	7.57e-05	0.000536	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PLA2G4A—autistic disorder	7.56e-05	0.000536	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—OXT—autistic disorder	7.51e-05	0.000532	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR1B—autistic disorder	7.51e-05	0.000532	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GABBR2—autistic disorder	7.46e-05	0.000528	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR2A—autistic disorder	7.37e-05	0.000522	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GZMB—autistic disorder	7.14e-05	0.000506	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DRD1—autistic disorder	7.13e-05	0.000505	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DRD1—autistic disorder	6.98e-05	0.000494	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR1B—autistic disorder	6.97e-05	0.000493	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—OXT—autistic disorder	6.97e-05	0.000493	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR1B—autistic disorder	6.93e-05	0.000491	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—OXT—autistic disorder	6.93e-05	0.000491	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DRD3—autistic disorder	6.91e-05	0.000489	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—OXT—autistic disorder	6.82e-05	0.000483	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR1B—autistic disorder	6.82e-05	0.000483	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR1D—autistic disorder	6.79e-05	0.000481	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—IL5—autistic disorder	6.76e-05	0.000479	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DRD3—autistic disorder	6.76e-05	0.000479	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR2A—autistic disorder	6.7e-05	0.000474	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CALCA—autistic disorder	6.68e-05	0.000473	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR1D—autistic disorder	6.65e-05	0.000471	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—IL5—autistic disorder	6.62e-05	0.000468	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRLR—autistic disorder	6.54e-05	0.000463	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CALCA—autistic disorder	6.53e-05	0.000463	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DRD1—autistic disorder	6.48e-05	0.000459	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—PRKCB—autistic disorder	6.46e-05	0.000458	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TSC1—autistic disorder	6.45e-05	0.000457	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DRD1—autistic disorder	6.45e-05	0.000457	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRLR—autistic disorder	6.4e-05	0.000453	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DRD1—autistic disorder	6.34e-05	0.000449	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GRM8—autistic disorder	6.32e-05	0.000447	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DRD3—autistic disorder	6.27e-05	0.000444	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NTRK2—autistic disorder	6.27e-05	0.000444	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DRD3—autistic disorder	6.24e-05	0.000442	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—PIK3CG—autistic disorder	6.19e-05	0.000438	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—POMC—autistic disorder	6.18e-05	0.000438	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GRM8—autistic disorder	6.18e-05	0.000438	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL5—autistic disorder	6.14e-05	0.000435	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DRD3—autistic disorder	6.14e-05	0.000435	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—WNT2—autistic disorder	6.12e-05	0.000433	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL5—autistic disorder	6.11e-05	0.000433	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CALCA—autistic disorder	6.07e-05	0.00043	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—POMC—autistic disorder	6.05e-05	0.000428	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CALCA—autistic disorder	6.04e-05	0.000428	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GHR—autistic disorder	6.03e-05	0.000427	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL5—autistic disorder	6.01e-05	0.000425	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—WNT2—autistic disorder	5.98e-05	0.000424	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PDE4A—autistic disorder	5.94e-05	0.000421	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CALCA—autistic disorder	5.93e-05	0.00042	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GHR—autistic disorder	5.89e-05	0.000417	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—POMC—autistic disorder	5.89e-05	0.000417	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PRKCB—autistic disorder	5.87e-05	0.000416	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PDE4A—autistic disorder	5.81e-05	0.000411	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PIK3CG—autistic disorder	5.62e-05	0.000398	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—ADRB2—autistic disorder	5.6e-05	0.000396	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AVPR1A—autistic disorder	5.56e-05	0.000394	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AVPR1A—autistic disorder	5.44e-05	0.000385	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GRM5—autistic disorder	5.37e-05	0.00038	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—VIP—autistic disorder	5.37e-05	0.00038	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—POMC—autistic disorder	5.35e-05	0.000379	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PRL—autistic disorder	5.33e-05	0.000378	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—AVP—autistic disorder	5.26e-05	0.000372	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—VIP—autistic disorder	5.25e-05	0.000372	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GRM5—autistic disorder	5.25e-05	0.000372	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—OXTR—autistic disorder	5.2e-05	0.000368	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SCT—autistic disorder	5.15e-05	0.000365	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—AVP—autistic disorder	5.14e-05	0.000364	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—OXTR—autistic disorder	5.09e-05	0.00036	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—ADRB2—autistic disorder	5.08e-05	0.00036	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADRB2—autistic disorder	5.06e-05	0.000358	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SCT—autistic disorder	5.04e-05	0.000357	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADM—autistic disorder	4.91e-05	0.000348	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GABBR1—autistic disorder	4.91e-05	0.000348	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EIF4E—autistic disorder	4.83e-05	0.000342	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GABBR1—autistic disorder	4.8e-05	0.00034	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADM—autistic disorder	4.8e-05	0.00034	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PDE4B—autistic disorder	4.79e-05	0.000339	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—AVP—autistic disorder	4.78e-05	0.000338	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—AVP—autistic disorder	4.75e-05	0.000337	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IGF2—autistic disorder	4.73e-05	0.000335	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EIF4E—autistic disorder	4.72e-05	0.000334	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PDE4B—autistic disorder	4.68e-05	0.000332	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—AVP—autistic disorder	4.67e-05	0.000331	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—OPRM1—autistic disorder	4.64e-05	0.000328	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—OPRM1—autistic disorder	4.53e-05	0.000321	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PLA2G4A—autistic disorder	4.49e-05	0.000318	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PLA2G4A—autistic disorder	4.47e-05	0.000316	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PLA2G4A—autistic disorder	4.39e-05	0.000311	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR2A—autistic disorder	4.38e-05	0.00031	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—IL2—autistic disorder	4.35e-05	0.000308	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MEF2C—autistic disorder	4.35e-05	0.000308	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR2A—autistic disorder	4.28e-05	0.000303	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GZMB—autistic disorder	4.24e-05	0.0003	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ITGB3—autistic disorder	4.24e-05	0.0003	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GZMB—autistic disorder	4.15e-05	0.000294	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—OXT—autistic disorder	4.12e-05	0.000291	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR1B—autistic disorder	4.12e-05	0.000291	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR1B—autistic disorder	4.03e-05	0.000285	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—OXT—autistic disorder	4.03e-05	0.000285	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR2A—autistic disorder	3.97e-05	0.000281	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR2A—autistic disorder	3.95e-05	0.00028	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL2—autistic disorder	3.95e-05	0.00028	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR2A—autistic disorder	3.89e-05	0.000275	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PRKCB—autistic disorder	3.84e-05	0.000272	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD1—autistic disorder	3.83e-05	0.000271	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TSC1—autistic disorder	3.83e-05	0.000271	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TSC2—autistic disorder	3.76e-05	0.000266	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PRKCB—autistic disorder	3.75e-05	0.000266	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD1—autistic disorder	3.74e-05	0.000265	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TSC1—autistic disorder	3.74e-05	0.000265	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NTRK2—autistic disorder	3.72e-05	0.000264	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD3—autistic disorder	3.71e-05	0.000262	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—LEP—autistic disorder	3.68e-05	0.00026	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—APOE—autistic disorder	3.68e-05	0.00026	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PIK3CG—autistic disorder	3.67e-05	0.00026	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NTRK2—autistic disorder	3.64e-05	0.000258	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL5—autistic disorder	3.63e-05	0.000257	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD3—autistic disorder	3.63e-05	0.000257	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PIK3CG—autistic disorder	3.59e-05	0.000254	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CALCA—autistic disorder	3.58e-05	0.000254	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL5—autistic disorder	3.55e-05	0.000251	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CALCA—autistic disorder	3.51e-05	0.000248	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—POMC—autistic disorder	3.49e-05	0.000247	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PRKCB—autistic disorder	3.48e-05	0.000247	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PRKCB—autistic disorder	3.47e-05	0.000246	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—POMC—autistic disorder	3.42e-05	0.000242	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PRKCB—autistic disorder	3.41e-05	0.000241	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PIK3CG—autistic disorder	3.33e-05	0.000236	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PIK3CG—autistic disorder	3.32e-05	0.000235	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—APC—autistic disorder	3.32e-05	0.000235	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EGF—autistic disorder	3.28e-05	0.000232	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PIK3CG—autistic disorder	3.26e-05	0.000231	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—POMC—autistic disorder	3.17e-05	0.000225	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRL—autistic disorder	3.17e-05	0.000224	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—POMC—autistic disorder	3.16e-05	0.000224	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—POMC—autistic disorder	3.1e-05	0.00022	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRL—autistic disorder	3.1e-05	0.000219	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IGF1—autistic disorder	3.04e-05	0.000215	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—MAPK1—autistic disorder	3.02e-05	0.000214	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADRB2—autistic disorder	3e-05	0.000213	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SERPINE1—autistic disorder	2.89e-05	0.000204	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—AVP—autistic disorder	2.82e-05	0.0002	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IGF2—autistic disorder	2.81e-05	0.000199	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—AVP—autistic disorder	2.76e-05	0.000195	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IGF2—autistic disorder	2.75e-05	0.000195	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PLA2G4A—autistic disorder	2.65e-05	0.000188	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PLA2G4A—autistic disorder	2.59e-05	0.000184	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—IL2—autistic disorder	2.58e-05	0.000183	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MEF2C—autistic disorder	2.58e-05	0.000183	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—IL2—autistic disorder	2.53e-05	0.000179	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MEF2C—autistic disorder	2.52e-05	0.000179	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ITGB3—autistic disorder	2.51e-05	0.000178	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ITGB3—autistic disorder	2.46e-05	0.000174	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HRAS—autistic disorder	2.43e-05	0.000172	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR2A—autistic disorder	2.35e-05	0.000166	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL2—autistic disorder	2.35e-05	0.000166	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL2—autistic disorder	2.34e-05	0.000165	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6—autistic disorder	2.32e-05	0.000165	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR2A—autistic disorder	2.3e-05	0.000163	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL2—autistic disorder	2.3e-05	0.000163	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TSC2—autistic disorder	2.23e-05	0.000158	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PTEN—autistic disorder	2.2e-05	0.000156	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—LEP—autistic disorder	2.18e-05	0.000155	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APOE—autistic disorder	2.18e-05	0.000155	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TSC2—autistic disorder	2.18e-05	0.000154	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APOE—autistic disorder	2.13e-05	0.000151	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—LEP—autistic disorder	2.13e-05	0.000151	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PRKCB—autistic disorder	2.06e-05	0.000146	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PRKCB—autistic disorder	2.01e-05	0.000143	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—APC—autistic disorder	1.97e-05	0.000139	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PIK3CG—autistic disorder	1.97e-05	0.000139	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EGF—autistic disorder	1.95e-05	0.000138	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—APC—autistic disorder	1.93e-05	0.000136	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PIK3CG—autistic disorder	1.93e-05	0.000136	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EGF—autistic disorder	1.9e-05	0.000135	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—POMC—autistic disorder	1.87e-05	0.000133	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—POMC—autistic disorder	1.83e-05	0.00013	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IGF1—autistic disorder	1.8e-05	0.000128	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—MAPK1—autistic disorder	1.79e-05	0.000127	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MAPK1—autistic disorder	1.79e-05	0.000126	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IGF1—autistic disorder	1.76e-05	0.000125	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—MAPK1—autistic disorder	1.76e-05	0.000124	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SERPINE1—autistic disorder	1.71e-05	0.000121	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SERPINE1—autistic disorder	1.68e-05	0.000119	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HRAS—autistic disorder	1.44e-05	0.000102	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HRAS—autistic disorder	1.43e-05	0.000102	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HRAS—autistic disorder	1.41e-05	9.98e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL2—autistic disorder	1.39e-05	9.82e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6—autistic disorder	1.38e-05	9.77e-05	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6—autistic disorder	1.37e-05	9.72e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL2—autistic disorder	1.36e-05	9.6e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6—autistic disorder	1.35e-05	9.55e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PTEN—autistic disorder	1.3e-05	9.24e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PTEN—autistic disorder	1.28e-05	9.03e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MAPK1—autistic disorder	1.06e-05	7.51e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MAPK1—autistic disorder	1.04e-05	7.34e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HRAS—autistic disorder	8.51e-06	6.03e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HRAS—autistic disorder	8.33e-06	5.9e-05	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6—autistic disorder	8.15e-06	5.77e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6—autistic disorder	7.97e-06	5.64e-05	CbGpPWpGaD
